SEARCH RESULTS FOR: "Tag: COLL"
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2019(2)
2018(2)
2017(2)
CATEGORIES
Analyst Update(4)
Buzz Stocks(1)
Stocks On the Move(2)

5/3/2019 11:32 AM
H.C. Wainwright just initiated coverage on the drugmaker Collegium Pharmaceutical, Inc (NASDAQ:COLL) with a "buy" rating and a $23 price target -- a roughly 60% upside to the stock's current perch at...
4/12/2019 10:13 AM
Shares of Collegium Pharmaceutical Inc (NASDAQ:COLL) are making positive moves this morning, just after landing a "buy" rating and $29 price target out of Janney Montgomery. This type of bull note is ...
6/12/2018 1:32 PM
The shares of healthcare concerns Collegium Pharmaceutical Inc (NASDAQ:COLL) and Stemline Therapeutics Inc (NASDAQ:STML) are higher today, thanks to some upbeat analyst attention. Specifically, Ca...
2/12/2018 3:13 PM
U.S. stocks are higher today, with the Dow last seen up around over 480 points. Among the stocks making notable moves today are online mailing and shipping name Stamps.com Inc. (NASDAQ:STMP), drugma...
12/5/2017 2:33 PM
U.S. stocks are slightly higher this afternoon. Among the names making big moves are homebuilder Toll Brothers Inc (NYSE:TOL), biotech Revance Therapeutics Inc (NASDAQ:RVNC), and pharma stock Colleg...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center